covid-19 recommendations vaccine

ACIP Evidence to Recommendations for Use of Moderna COVID-19 Vaccine under an Emergency Use Authorization

Reading now: 245
www.cdc.gov

ACIP website.The clinical trial for the Moderna COVID-19 vaccine demonstrated very high efficacy of the 2-dose regimen against symptomatic, laboratory-confirmed COVID-19.1,2 The overall efficacy* was 94.1% (95% Confidence Interval [CI]: 89.3%, 96.8%).

Consistent high efficacy (≥86%) was observed across age, sex, race, ethnicity, and among those at risk for severe COVID-19.Nine persons in the placebo group and one in the vaccine group were hospitalized with COVID-19.3 Vaccine efficacy against hospitalization due to COVID-19 was 89% (95% CI: 13%, 89%).

Deaths were also uncommon, 6 in the vaccine group and 7 in the placebo group.Post-marketing surveillance will be critical to detect any rare serious adverse events which were not identified in.

Read more on cdc.gov
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA